‹ ›
MYP_092331
← PREVIOUS NEXT → BACK
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
21 amino acids
C96H158N34O34
Standard
Sequence
AGHATLREHLRDIKAENTDAN
Physicochemical Analysis
2332.49 Da
6.02
-1.02
-1.32
-0.0487
-1.09
0.62
-0.28
16.19
74.76
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1128.34
-14.28
39.0
35.0
79.0
164.0
2.0
22.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0225378 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 19.0%, E 0.0%, T 47.6%, C 33.3% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
PaperAVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses PMID24285301 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24285301/
RECORD: Rec_0369489 VERIFIED: YES
Provenance & Taxonomy
Human alphaherpesvirus 1 [Virus]
Heptad repeat peptide
10298;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
Herpes simplex virus 1 (Virus entry); Vero
Plaque assay
PaperAnalysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B. | Galdiero S, Vitiello M, D'Isanto M, Falanga A, Collins C, Raieta K, Pedone C, Browne H, Galdiero M. | J Gen Virol. 2006 | PMID:16603508 PMID16603508 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/16603508/